Ms. Caperelli joined Arbutus in September 2021 as Vice President Investor Relations.  Ms. Caperelli has more than 20 years of demonstrated experience in leading investor communications strategies for publicly traded biotechnology companies. Prior to joining Arbutus, Lisa oversaw investor relations at Harmony, where she assisted the company in its IPO, increased analyst coverage and generated investor education and awareness around the company’s first year of sales for its FDA approved product. Throughout her career, Ms. Caperelli held roles of increased responsibility in investor relations and corporate communications with several public biotech companies at various stages of development including Marinus Pharmaceuticals, Advaxis, Inc., PolyMedix and Windtree Therapeutics, Inc. (formerly Discovery Labs).  In these roles, Lisa clearly and concisely communicated the company’s strategy, growth opportunities and business initiatives to the buy- and sell-side and secured in excess of $500m in capital through various financings.  Ms. Caperelli holds a Bachelor of Science in Business Administration from Delaware Valley University. She is a board member of NIRI: The Association for Investors Relations and Advisor, Immediate Past President of the Philadelphia Chapter.